CD8A and neoplasm: Mice given with Bifidobacterium had considerably better tumor control than mice not treated with Bifidobacterium, and this improvement was supported by an effective induction of peripheral tumor-specific T cells and an increase in the buildup of CD8+ T cells specific to the antigen within tumors.